HomeExpert Team Expert Team

Expert Team

Bringing specialists together to find the most suitable treatment option for every cancer patient.

Expert Team

Bringing specialists together to find the most suitable treatment option for every cancer patient.
Filter Providers By
Expert Team
Filter Providers By
Close
Search for medical departments based on the first letter of pinyin
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z
no data

No relevant content available

Explanatory text explanatory text explanatory text

  • 3
  • 4
  • 5
  • 6
  • 7
Filter Providers By
Search for medical departments based on the first letter of pinyin
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z
  • Chu Shikui
    Chu Shikui
    Specializes in comprehensive minimally invasive interventional therapy for various malignant tumors, including pancreatic, breast, colorectal, liver, lung, renal, prostate, bladder, cervical, and ovarian cancers, as well as head and neck tumors.
    Profile:
    Fosun Cancer Hospital Guangzhou, Chu Shikui, Associate Chief Physician of Oncology Ward 3 at Guangzhou Fosun Chancheng Hospital. With years of experience in clinical oncology diagnosis and treatment, he has performed over 20,000 interventional procedures. He specializes in minimally invasive interventional combination therapy for various malignant tumors—including pancreatic, breast, colorectal, liver, lung, and renal cancers, as well as genitourinary malignancies—and is proficient in techniques such as perfusion chemotherapy, embolization, ablation, and radioactive seed implantation.
  • Sun Zhengyu
    Sun Zhengyu
    Specializes in comprehensive interventional therapy for systemic solid malignant tumors, including liver, lung, breast, pancreatic, cervical, renal, bladder, esophageal, and gastrointestinal cancers.
    Profile:
    Fosun Cancer Hospital Guangzhou, Sun Zhengyu, Chief Physician of Oncology Ward 3 at Guangzhou Fosun Chancheng Hospital. Formerly the Director of Interventional Radiology at Harbin First Hospital, he has long focused on minimally invasive interventional therapy for malignant tumors. He specializes in comprehensive interventional treatment for solid malignancies—including liver, lung, breast, pancreatic, cervical, and renal cancers, as well as gastrointestinal tumors—and is proficient in techniques such as transarterial chemoembolization (TACE) and thermal/cryo-ablation.
  • Jia Jun
    Jia Jun
    Specializes in medical therapies—including chemotherapy, targeted therapy, and immunotherapy—and multidisciplinary comprehensive treatment for various malignant tumors, particularly lung cancer, gastrointestinal tumors, breast cancer, and tumors of the head and neck and genitourinary systems.
    Profile:
    Fosun Cancer Hospital Guangzhou, Jia Jun, Chief Physician and Professor in the Department of Oncology (Ward 3) at Foshan Fosun Chancheng Hospital; former Director of the Cancer Prevention and Treatment Center and academic leader in medical oncology. With over 30 years of experience in clinical oncology, research, and teaching, she specializes in chemotherapy, targeted therapy, and immunotherapy for lung cancer, gastrointestinal tumors, breast cancer, and tumors of the head and neck and genitourinary systems. She also possesses expertise in precision medicine and multidisciplinary comprehensive treatment for complex and challenging tumors.
  • Zeng Zongyuan
    Zeng Zongyuan
    Specializes in the diagnosis and treatment of head and neck tumors; renowned as a "zero-bleeding" expert who pioneered a unique intraoperative hemostatic suturing technique, achieving outstanding results in surgeries for thyroid tumors, parotid gland tumors, and facial/neck hemangiomas.
    Profile:
    Fosun Cancer Hospital Guangzhou, Zeng Zongyuan, Chief Physician, Professor, and Doctoral Supervisor at the Department of Oncology (Ward 3), Foshan Fosun Chancheng Hospital; expert recipient of the State Council Special Allowance; formerly Deputy Director and Head of the Head and Neck Department at the Cancer Center of Sun Yat-sen University. He has long been engaged in the diagnosis, treatment, and research of head and neck tumors, with particular expertise in the surgical treatment of laryngeal cancer, oral cancer, and tumors of the thyroid, parotid gland, and other head and neck regions.
  • Tang Rijie
    Tang Rijie
    Specializes in precision treatment for various intermediate- and advanced-stage tumors; possesses unique insights into managing recurrent and metastatic malignancies—such as lung, liver, breast, colorectal, gastric, and cervical cancers, as well as sarcomas and head and neck tumors—and complex clinical cases.
    Profile:
    Fosun Cancer Hospital Guangzhou, Tang Rijie, Chief Physician, Professor, and Doctoral Supervisor at the Department of Oncology (Ward 3), Guangzhou Fosun Chancheng Hospital. With over 40 years of experience in clinical oncology and research, he specializes in minimally invasive interventional therapy for tumors and precision treatment for various mid-to-late-stage cancers. He possesses extensive clinical experience in treating lung, liver, breast, colorectal, and gastric cancers, as well as recurrent/metastatic malignancies and complex cases.
no data

No relevant content available

Explanatory text explanatory text explanatory text

  • 3
  • 4
  • 5
  • 6
  • 7

Why Choose Us

  • 26,000+
    Over 26,000 international patient visits from 124 countries and regions.
  • 1,000+
    Over 1,000 cancer patients treated with our sixth-generation CyberKnife.
  • 800+
    Over 800 patients treated with the da Vinci Surgical System since April 2023.
  • 500+
    Personalized treatment plans developed for over 500 patients through China–U.S. MDT consultations.

Why Choose Us

  • 26,000+
    Over 26,000 international patient visits from 124 countries and regions.
  • 1,000+
    Over 1,000 cancer patients treated with our sixth-generation CyberKnife.
  • 800+
    Over 800 patients treated with the da Vinci Surgical System since April 2023.
  • 500+
    Personalized treatment plans developed for over 500 patients through China–U.S. MDT consultations.